Equity Profile

ICUI

ICU Medical, Inc.

Health CareHealth Care Supplies$3.9B

Aug6Thu

Pre-Earnings Brief

UpcomingQ2-2026After Close5:00 PM EDT

Company Snapshot

ICU Medical, Inc. is a healthcare company that specializes in medical supplies, particularly infusion systems and devices....

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a critical measure of a company's profitability and will indicate how well ICU Medical is managing its costs and revenues.

N/A

Revenue Growth

Revenue growth is vital to assess the company's ability to expand its market share and meet increasing demand for healthcare supplies.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

ICUI Q2-2026 Earnings Preview

Context

Company Snapshot

ICU Medical, Inc. is a healthcare company that specializes in medical supplies, particularly infusion systems and devices. As a key player in the health care sector, its products are essential for safe and effective patient care, making it an important company to watch in the evolving healthcare landscape.

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+86.10%

Avg Stock Reaction

+0.93%

Last Quarter Recap

In Q1-2026, ICU Medical reported an EPS of $1.97, significantly beating estimates by 48%. The stock reacted positively, gaining 2.91% the following day.

Management Promises & Guidance

Focus on improving supply chain efficiency.
Commitment to expanding product offerings in infusion systems.
Plans to enhance customer service and support.

Expectations

Wall Street Expectations

Overall, expectations for ICU Medical are cautiously optimistic, given its strong earnings history. Investors are looking for continued growth and profitability.

Bull Case

If ICU Medical maintains its trend of beating earnings estimates, it could signal robust demand for its products and a strong market position.

Bear Case

Conversely, any sign of slowing revenue growth or increased costs could raise concerns about the company's future profitability.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will the EPS be for Q2-2026, and how does it compare to previous quarters?

Given ICU Medical's history of beating EPS estimates, this number will be crucial for investor confidence.

How is the company addressing supply chain challenges and cost management?

With rising costs in the healthcare sector, effective management of these issues will be key to maintaining profitability.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating ICU Medical's ability to manage costs effectively, which could lead to higher-than-expected margins.

Supporting Evidence

The company has consistently beaten EPS estimates, indicating strong operational control.

Options pricing suggests a larger move than historical averages, hinting at potential surprises.

Management's focus on supply chain improvements could mitigate cost pressures.

Key Risk

If the EPS comes in below $1.70, it could challenge the current bullish sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The core debate this quarter revolves around whether ICU Medical can sustain its impressive earnings growth amidst potential cost pressures.

Bull Confirmed If

Earnings per share exceeding $2.00 would confirm strong operational performance and growth.

Bear Confirmed If

An EPS below $1.70 could raise concerns about profitability and cost management.

Pre-Earnings Positioning

Options Market

Implied Move

±5.31%

Historical Avg

±2.4%

Pricing rich

The options market is pricing in a significant move, suggesting that traders expect volatility around the earnings announcement.

Options are pricing ±5.3% while ICUI has averaged ±2.4% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.5%

30d HV

35.6%

Calls (6K)P/C Ratio: 0.02Puts (100)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If ICU Medical beats expectations and raises guidance, history suggests the stock could rise by around 0.93% on the first day.

In-Line / Cautious

If results are in line with expectations but management provides cautious commentary, the stock may see a muted reaction.

Miss

A miss on earnings could lead to a decline, with historical patterns suggesting a potential drop of around 2.09%.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Details on supply chain management and cost control measures.
2Updates on new product launches and market expansion plans.
3Any changes in guidance for future quarters.
4Insights into customer demand trends for infusion systems.
5Management's outlook on industry challenges and opportunities.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Danaos Corporation

Company Snapshot

ICU Medical, Inc. is a healthcare company that specializes in medical supplies, particularly infusion systems and devices....

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a critical measure of a company's profitability and will indicate how well ICU Medical is managing its costs and revenues.

N/A

Revenue Growth

Revenue growth is vital to assess the company's ability to expand its market share and meet increasing demand for healthcare supplies.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

ICUI Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+86.10%

Avg Stock Reaction

+0.93%

Last Quarter Recap

In Q1-2026, ICU Medical reported an EPS of $1.97, significantly beating estimates by 48%. The stock reacted positively, gaining 2.91% the following day.

Management Promises & Guidance

Focus on improving supply chain efficiency.
Commitment to expanding product offerings in infusion systems.
Plans to enhance customer service and support.

Expectations

Wall Street Expectations

Overall, expectations for ICU Medical are cautiously optimistic, given its strong earnings history. Investors are looking for continued growth and profitability.

Bull Case

If ICU Medical maintains its trend of beating earnings estimates, it could signal robust demand for its products and a strong market position.

Bear Case

Conversely, any sign of slowing revenue growth or increased costs could raise concerns about the company's future profitability.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will the EPS be for Q2-2026, and how does it compare to previous quarters?

Given ICU Medical's history of beating EPS estimates, this number will be crucial for investor confidence.

How is the company addressing supply chain challenges and cost management?

With rising costs in the healthcare sector, effective management of these issues will be key to maintaining profitability.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating ICU Medical's ability to manage costs effectively, which could lead to higher-than-expected margins.

Supporting Evidence

The company has consistently beaten EPS estimates, indicating strong operational control.

Options pricing suggests a larger move than historical averages, hinting at potential surprises.

Management's focus on supply chain improvements could mitigate cost pressures.

Key Risk

If the EPS comes in below $1.70, it could challenge the current bullish sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The core debate this quarter revolves around whether ICU Medical can sustain its impressive earnings growth amidst potential cost pressures.

Bull Confirmed If

Earnings per share exceeding $2.00 would confirm strong operational performance and growth.

Bear Confirmed If

An EPS below $1.70 could raise concerns about profitability and cost management.

Pre-Earnings Positioning

Options Market

Implied Move

±5.31%

Historical Avg

±2.4%

Pricing rich

The options market is pricing in a significant move, suggesting that traders expect volatility around the earnings announcement.

Options are pricing ±5.3% while ICUI has averaged ±2.4% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.5%

30d HV

35.6%

Calls (6K)P/C Ratio: 0.02Puts (100)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If ICU Medical beats expectations and raises guidance, history suggests the stock could rise by around 0.93% on the first day.

In-Line / Cautious

If results are in line with expectations but management provides cautious commentary, the stock may see a muted reaction.

Miss

A miss on earnings could lead to a decline, with historical patterns suggesting a potential drop of around 2.09%.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Details on supply chain management and cost control measures.
2Updates on new product launches and market expansion plans.
3Any changes in guidance for future quarters.
4Insights into customer demand trends for infusion systems.
5Management's outlook on industry challenges and opportunities.